Login / Signup

Breaking the mold: asciminib as a standard of care of the therapeutic armamentarium of chronic myeloid leukemia in the upfront setting.

Reyhan YılmazAhmet Emre Eskazan
Published in: Future oncology (London, England) (2023)
Keyphrases
  • chronic myeloid leukemia
  • healthcare
  • palliative care
  • quality improvement
  • affordable care act
  • pain management
  • health insurance